We build algorithms around your patients’ unique needs.

Our mission is to offer physician support by providing powerful data analysis for patients with a variety of medical conditions. We partner with companies or clinical practices working with data that requires additional context – particularly in the space of clinical imaging. Our targeted approach enables physicians to make more informed decisions with each patient’s unique data set.

Answers with greater precision and efficiency.

We seek to combine relevant biomarkers and multi-modality imaging to answer key questions about precision health care, including:

·        Diagnosis: Among a variety of possible diagnoses, which is most likely?

·        Prognosis: With no intervention, what can we expect will happen?

·        Best Alternative: What is the best next step?

·        Go/No Go: Should a certain type of care be provided or not?

·        How To: How much of this treatment should be given and in what dosing regimen?

·        Prediction: How well can we expect this treatment to work?

·        Monitoring: When do we cease treatment and/or pivot to something different?

Imaging companies in the AI space focus on clinical workflow improvement, enhancement of image reconstruction and presentation, image interpretation, and predictive analytics.  PlenaryAI has and will continue to develop products along those lines with a focus on enhancement of molecular imaging modalities, i.e., those that interrogate human biochemistry in its unperturbed state, without the need for concurrent surgery, biopsy or other invasive procedures.  Unlike computed tomography or magnetic resonance imaging, which depict anatomy with exquisite spatial resolution, molecular imaging can gauge specific, dynamic biochemical processes non-invasively and repeatedly.  Biochemistry is where the earliest aspects of disease become evident.  Combining molecular imaging with anatomic modalities, fluid-based biomarkers and advanced analytic techniques such as AI will enable early, actionable therapeutic decisions.

PlenaryAI’s Advantage

Academic leaders in imaging and molecular imaging research, steeped in the nuances of medical management through imaging, guide PlenaryAI.  Domain expertise extends from basic physics, organic chemistry, statistics and computer science to radiology, nuclear medicine and state-of-the-art clinical practice.  As part of two thriving biomedical research systems, Johns Hopkins University and the University of Maryland Medical Center, PlenaryAI has access to the latest technology, clinical services, data and medical thinking to realize precision health.  PlenaryAI is also linked to Precision Molecular, a subsidiary of D&D Pharmatech, which provides the imaging agents that target specific molecular processes, some of which have been translated to human use and are being disseminated worldwide for managing cancer and neuroinflammation.  Led by domain experts, and with access to data and technologies enmeshed within two healthcare systems, PlenaryAI is nimble and poised for impact in precision medicine and health.